All news

An investment manager reports over 10% of Alnylam (ALNY), with no shared voting power.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Capital World Investors reported a beneficial ownership of 13,934,539 shares, representing 10.4% of Alnylam Pharmaceuticals, Inc. (ALNY) common stock, as of September 30, 2026. The investment manager maintains sole voting power over 13,889,698 shares and sole dispositive power over 13,934,539 shares, with no shared voting or dispositive power reported. This filing was made under Schedule 13G/A, indicating a passive investment.

Read original source

ALNY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.